Daily Choice Neuro-X Advance Capsule
Daily Choice Neuro-X Advance Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
Benfotiamine is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-15021. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| ALPHA LIPOIC ACID | ALPHA LIPOIC ACID[100 mg,450 mg] | Not identified |
| BENFOTIAMINE | BENFOTIAMINE[50 mg,450 mg] | Not identified |
| METHYLCOBALAMIN | METHYLCOBALAMIN[50 mg,450 mg] | Vitamine B12 |
| PYRIDOXINE HYDROCHLORIDE | PYRIDOXINE HYDROCHLORIDE[50 mg,450 mg] | Vitamine B6 |
| MAGNESIUM CITRATE | MAGNESIUM CITRATE[150 mg,450 mg] | Magnésium |
| ZINC GLUCONATE | ZINC GLUCONATE[20 mg,450 mg] | Zinc |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL21026140NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- ANTARES PHARMA SDN. BHD.
- Manufacturer
- EXCEL HERBAL INDUSTRIES SDN. BHD.
- Registration period starting
- 2026-03-05
- Published validity end
- 2031-03-05
Original register data
View published fields and their variants
- Active ingredients
- ALPHA LIPOIC ACID[100 mg,450 mg],BENFOTIAMINE[50 mg,450 mg],METHYLCOBALAMIN[50 mg,450 mg],PYRIDOXINE HYDROCHLORIDE[50 mg,450 mg],MAGNESIUM CITRATE[150 mg,450 mg],ZINC GLUCONATE[20 mg,450 mg]
- Valid until
- 2031-03-05
- Registration date
- 2026-03-05
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- ANTARES PHARMA SDN. BHD.
- Producer
- EXCEL HERBAL INDUSTRIES SDN. BHD.
- Published name
- Daily Choice Neuro-X Advance Capsule
- Published reference
- 202012174632N
- Registration number
- MAL21026140NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL21026140NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Daily Choice Neuro-X Advance Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL21026140NC-daily-choice-neuro-x-advance-capsule, updated 27 October 2026.